Hill-Rom Holdings, Inc. (NYSE:HRC) has been assigned a consensus rating of “Hold” from the eleven ratings firms that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $99.63.

HRC has been the subject of several research analyst reports. Zacks Investment Research raised shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $98.00 price objective for the company in a report on Monday, July 2nd. KeyCorp upped their price objective on shares of Hill-Rom from $97.00 to $115.00 and gave the stock an “overweight” rating in a report on Tuesday, July 17th. Raymond James upped their price objective on shares of Hill-Rom from $97.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, July 30th. Northcoast Research reaffirmed a “buy” rating and issued a $104.00 price objective on shares of Hill-Rom in a report on Tuesday, July 31st. Finally, ValuEngine raised shares of Hill-Rom from a “hold” rating to a “buy” rating in a report on Tuesday, July 31st.

A number of hedge funds have recently bought and sold shares of the stock. Russell Investments Group Ltd. lifted its holdings in Hill-Rom by 520.7% in the 1st quarter. Russell Investments Group Ltd. now owns 92,810 shares of the medical technology company’s stock valued at $8,070,000 after acquiring an additional 77,857 shares during the last quarter. Stifel Financial Corp lifted its holdings in Hill-Rom by 15.6% in the 1st quarter. Stifel Financial Corp now owns 5,048 shares of the medical technology company’s stock valued at $441,000 after acquiring an additional 680 shares during the last quarter. Commonwealth Equity Services LLC lifted its holdings in Hill-Rom by 8.0% in the 1st quarter. Commonwealth Equity Services LLC now owns 11,688 shares of the medical technology company’s stock valued at $1,016,000 after acquiring an additional 866 shares during the last quarter. Northwestern Mutual Investment Management Company LLC lifted its holdings in Hill-Rom by 57.1% in the 1st quarter. Northwestern Mutual Investment Management Company LLC now owns 13,540 shares of the medical technology company’s stock valued at $1,178,000 after acquiring an additional 4,920 shares during the last quarter. Finally, Barclays PLC lifted its holdings in Hill-Rom by 21.3% in the 1st quarter. Barclays PLC now owns 17,404 shares of the medical technology company’s stock valued at $1,513,000 after acquiring an additional 3,051 shares during the last quarter. 81.20% of the stock is owned by institutional investors and hedge funds.

Shares of HRC traded down $1.23 during midday trading on Thursday, hitting $87.30. 306,370 shares of the stock traded hands, compared to its average volume of 540,865. The company has a market cap of $5.80 billion, a price-to-earnings ratio of 19.66, a price-to-earnings-growth ratio of 1.23 and a beta of 0.89. Hill-Rom has a 1-year low of $75.21 and a 1-year high of $98.96. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.18 and a current ratio of 1.58.

Hill-Rom (NYSE:HRC) last posted its quarterly earnings data on Friday, July 27th. The medical technology company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.02. The business had revenue of $708.60 million during the quarter, compared to the consensus estimate of $707.50 million. Hill-Rom had a net margin of 8.19% and a return on equity of 20.54%. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.91 earnings per share. Analysts predict that Hill-Rom will post 4.64 EPS for the current year.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Recommended Story: What does relative strength index mean?

Analyst Recommendations for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.